These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37540483)

  • 21. Stigma of sickle cell disease among Indian tribal population: A multi-centric qualitative study.
    Bhat D; Babu BV; Surti SB; Ranjit M; Sarmah J; Sridevi P; Sharma Y
    J Natl Med Assoc; 2023 Dec; 115(6):556-565. PubMed ID: 37845145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haplotypes in tribal Indians bearing the sickle gene: evidence for the unicentric origin of the beta S mutation and the unicentric origin of the tribal populations of India.
    Labie D; Srinivas R; Dunda O; Dode C; Lapoumeroulie C; Devi V; Devi S; Ramasami K; Elion J; Ducrocq R
    Hum Biol; 1989 Aug; 61(4):479-91. PubMed ID: 2480325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India.
    Chourasia S; Kumar R; Singh MPSS; Vishwakarma C; Gupta AK; Shanmugam R
    Hemoglobin; 2020 Nov; 44(6):391-396. PubMed ID: 33222570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers and Facilitators of Premarital Genetic Counseling for Sickle Cell Disease in Northern Nigeria.
    Galadanci AA; Estepp JH; Khan H; Farouk ZL; Caroll Y; Hodges J; Yarima S; Ibrahim UA; Idris IM; Gambo A; Hussaini N; Mukaddas A; DeBaun MR; Galadanci NA
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e716-e722. PubMed ID: 37494609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intervention and prevention of hereditary hemolytic disorders in India: a case study of two ethnic communities of Sundargarh district in Orissa.
    Balgir RS
    J Assoc Physicians India; 2008 Nov; 56():851-8. PubMed ID: 19263682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caring for Africa's sickle cell children: will we rise to the challenge?
    Oron AP; Chao DL; Ezeanolue EE; Ezenwa LN; Piel FB; Ojogun OT; Uyoga S; Williams TN; Nnodu OE
    BMC Med; 2020 Apr; 18(1):92. PubMed ID: 32340612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of the β(S) gene among scheduled castes, scheduled tribes and other backward class groups in Central India.
    Shrikhande AV; Arjunan A; Agarwal A; Dani A; Tijare J; Gettig E; Krishnamurti L
    Hemoglobin; 2014; 38(4):230-5. PubMed ID: 25023085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity and divergence among the tribal populations of India.
    Watkins WS; Prasad BV; Naidu JM; Rao BB; Bhanu BA; Ramachandran B; Das PK; Gai PB; Reddy PC; Reddy PG; Sethuraman M; Bamshad MJ; Jorde LB
    Ann Hum Genet; 2005 Nov; 69(Pt 6):680-92. PubMed ID: 16266407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies to improve healthcare services for patients with sickle cell disease in Nigeria: The perspectives of stakeholders.
    Isa H; Okocha E; Adegoke SA; Nnebe-Agumadu U; Kuliya-Gwarzo A; Sopekan A; Ofakunrin AO; Ugwu N; Hassan AA; Ohiaeri C; Madu A; Diaku-Akinwumi I; Ekwem L; Dogara LG; Okoh D; Jasini J; Girei A; Ekwere T; Okolo A; Kangiwa U; Lawson J; Chianumba R; Brown B; Akinola N; Nwegbu M; Nnodu O
    Front Genet; 2023; 14():1052444. PubMed ID: 36816043
    [No Abstract]   [Full Text] [Related]  

  • 30. Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
    Russo G; De Franceschi L; Colombatti R; Rigano P; Perrotta S; Voi V; Palazzi G; Fidone C; Quota A; Graziadei G; Pietrangelo A; Pinto V; Ruffo GB; Sorrentino F; Venturelli D; Casale M; Ferrara F; Sainati L; Cappellini MD; Piga A; Maggio A; Forni GL
    Orphanet J Rare Dis; 2019 May; 14(1):120. PubMed ID: 31146777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives in Genetics and Sickle Cell Disease Prevention in Africa: Beyond the Preliminary Data from Cameroon.
    Wonkam A; Ngo Bitoungui VJ; Ngogang J
    Public Health Genomics; 2015; 18(4):237-41. PubMed ID: 26044545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing knowledge of sickle cell disease and health beliefs on premarital genetic screening among healthcare trainees at a tertiary institution: A cross-sectional study.
    Agbozo WK; Amanor E; Acheampong EO; Kotei B; Attoh LN; Yeboah D; Odonkor P; Obiri S; Kwarteng A; Larbi A
    Health Sci Rep; 2023 Feb; 6(2):e1128. PubMed ID: 36846532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endline assessment of knowledge about sickle cell disease among the tribal community of Chhotaudepur district of Gujarat.
    Surti SB; Parmar A; Babu BV; Patel GM; Godara N; Mishra U; Patel S
    J Community Genet; 2024 Apr; 15(2):187-194. PubMed ID: 38334932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indian sickle cell disease registry for surveillance and patient management: Development and implementation.
    Babu BV; Sharma Y; Surti SB; Bhat D; Sridevi P; Ranjit M; Sudhakar G; Sarmah J
    Int J Health Plann Manage; 2023 Sep; 38(5):1483-1494. PubMed ID: 37340519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sickle cell disease in India: a scoping review from a health systems perspective to identify an agenda for research and action.
    Raman V; Seshadri T; Joice SV; N Srinivas P
    BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33602689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn Screening for Sickle Cell Disease Among Tribal Populations in the States of Gujarat and Madhya Pradesh in India: Evaluation and Outcome Over 6 Years.
    Thaker P; Colah RB; Patel J; Raicha B; Mistry A; Mehta V; Italia Y; Desai S; Dave K; Shanmugam R; Ghosh K; Mukherjee MB
    Front Med (Lausanne); 2021; 8():731884. PubMed ID: 35242766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community expansion and gene geography of sickle cell trait and G6PD deficiency, and natural selection against malaria: experience from tribal land of India.
    Balgir RS
    Cardiovasc Hematol Agents Med Chem; 2012 Mar; 10(1):3-13. PubMed ID: 22264009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualized Homeopathic and Organopathic Supportive Management of Sickle Cell Disorder: A Case Series of Six Patients from a Particularly Vulnerable Tribal Group in India.
    Nambison NKM; Sharma N; Dwivedi AD; Chakravarty N
    Homeopathy; 2024 Nov; 113(4):253-261. PubMed ID: 38290537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Splenomegaly and Splenic Complications in Adults with Sickle Cell Disease and Its Relation to Fetal Hemoglobin.
    Lakhani JD; Gill R; Mehta D; Lakhani SJ
    Int J Hematol Oncol Stem Cell Res; 2022 Oct; 16(4):198-208. PubMed ID: 36883109
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of Microchip-Based Point-Of-Care Device "Gazelle" for Diagnosis of Sickle Cell Disease in India.
    Shrivas S; Patel M; Kumar R; Gwal A; Uikey R; Tiwari SK; Verma AK; Thota P; Das A; Bharti PK; Shanmugam R
    Front Med (Lausanne); 2021; 8():639208. PubMed ID: 34722554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.